EU: Vifor Tries Again With Avacopan Using ‘More Powerful’ Data

US Filing Was Submitted In September

Vifor Pharma has resubmitted a marketing application for avacopan to the European Medicines Agency – this time for an unconditional approval.

People, health care and medicine concept - unhappy man suffering from pain in back or kidneys sitting on bench on street
ANCA-associated vasculitis is a group of rare kidney autoimmune diseases • Source: Shutterstock

More from Product Reviews

More from Pink Sheet